semaglutide plus cagrilintide and have each been shown to induce weight loss, but how these drugs work in combination in patients with type 2 diabetes and overweight or obesity is unknown. Research findings ADA: Once-weekly cagrilintide + semaglutide

While AHK-Cu specific skin studies are limited, the shared mechanisms suggest similar benefits

Natural amylin acts on three receptor subtypes in the brain

Lactate dehydrogenase (LDH) is a cytosolic enzyme and its presence in the media is often used as an indicator for cellular toxicity

The rich network of blood vessels in this region carries the peptide directly into systemic circulation

Both may be contraindicated if you have: Personal or family history of medullary thyroid carcinoma, Multiple Endocrine Neoplasia syndrome type 2, history of severe pancreatitis, current pregnancy or plans to become pregnant, or severe kidney disease